• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】12714

【品名】diethyl phosphonate; diethyl phosphite

【CA登记号】762-04-9

【 分 子 式 】C4H11O3P

【 分 子 量 】138.103302

【元素组成】C 34.79% H 8.03% O 34.76% P 22.43%

与该中间体有关的原料药合成路线共 9 条

合成路线1

该中间体在本合成路线中的序号:(A)

3) By reaction of 4-methoxybenzylamine (I) with methyl isothiocyanate (B) in ether to yield N-(4-methoxybenzyl)-N'-methylthiourea (III), which is then methylated with MeI in refluxing methanol affording N-(4-methoxybenzyl)-N',S-dimethylisothiourea (IV). Finally, this compound is treated first with methylamine in refluxing methanol and then with H2SO4.

1 Castaner, J.; Loren, J.G.; Cefoxitin. Drugs Fut 1978, 3, 6, 434.
2 Christensen, B.G.; Ratcliffe, R.W.; Total synthesis of beta-lactam antibiotics. I. alpha-Thioformamido-diethylphosphonioacetates. Tetrahedron Lett 1973, 46, 4645-48.
3 Christensen, B.G.; Ratcliffe, R.W.; Total synthesis of beta-lactam antibiotics. II. (rac)-Cephalotin. Tetrahedron Lett 1973, 46, 4649-52.
4 Christensen, B.G.; Ratcliffe, R.W. (Merck & Co., Inc.); 7-Azido-cephalosporin compounds and their preparation. DE 2365406; FR 2182953; GB 1424373; JP 49014488 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(B) 10498 Benzaldehyde;Benzoic aldehyde;Phenylmethanal 100-52-7 C7H6O 详情 详情
(A) 12714 diethyl phosphonate; diethyl phosphite 762-04-9 C4H11O3P 详情 详情
(I) 39815 1,3,5-tribenzyl-1,3,5-triazinane 2547-66-2 C24H27N3 详情 详情
(II) 39816 diethyl (benzylamino)methylphosphonate C12H20NO3P 详情 详情
(III) 39817 diethyl aminomethylphosphonate C5H14NO3P 详情 详情
(IV) 39818 diethyl [[(E)-benzylidene]amino]methylphosphonate 50917-73-2 C12H18NO3P 详情 详情
(V) 39819 1-[[(chlorocarbonyl)oxy]methyl]-4-methoxybenzene C9H9ClO3 详情 详情
(VI) 39820 4-methoxybenzyl 2-(diethoxyphosphoryl)-2-[[(E)-benzylidene]amino]acetate C21H26NO6P 详情 详情
(VII) 39821 4-methoxybenzyl 2-amino-2-(diethoxyphosphoryl)acetate C14H22NO6P 详情 详情
(VIII) 39822 O-ethyl thioformate C3H6OS 详情 详情
(IX) 39823 4-methoxybenzyl 2-(diethoxyphosphoryl)-2-(thioformylamino)acetate C15H22NO6PS 详情 详情
(X) 39824 3-chloro-2-oxopropyl acetate 40235-68-5 C5H7ClO3 详情 详情
(XI) 39825 4-methoxybenzyl 5-[(acetoxy)methyl]-6H-1,3-thiazine-4-carboxylate C16H17NO5S 详情 详情
(XII) 39826 2-azidoacetyl chloride C2H2ClN3O 详情 详情
(XIII) 39827 4-methoxybenzyl (6R,7R)-3-[(acetoxy)methyl]-7-azido-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate C18H18N4O6S 详情 详情
(XIV) 39828 4-methoxybenzyl (6R,7R)-3-[(acetoxy)methyl]-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate C18H20N2O6S 详情 详情
(XV) 39829 4-methoxybenzyl (6R,7R)-3-[(acetoxy)methyl]-7-[[(E)-(4-nitrophenyl)methylidene]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate C25H23N3O8S 详情 详情
(C) 18184 4-Nitrobenzaldehyde 555-16-8 C7H5NO3 详情 详情

合成路线2

该中间体在本合成路线中的序号:(III)

1) The condensation of 1,3-dibromopropane (II) with diethyl phosphonate (III) gives diethyl 3-bromopropylphosphonate (IV), which by reaction with butyraldehyde oxime (V) by means of sodium ethoxide in ethanol is converted to diethyl 3-(butylideneamino)propylphosphonate-N-oxide (VI). Finally, this compound is hydrolyzed with HCl in refluxing acetic acid to obtain compound (I). 2) The condensation of (IV) with N-(p-methoxybenzyloxy)-p-toluenesulfonamide (VII) by means of sodium ethoxide in ethanol gives diethyl 3-[N-methoxybenzyloxy)-N-tosylamino]propyl phosphonate (VIII), which is hydrolyzed with HCl in acetic acid to obtain compound (I). 3) The condensation of (IV) with methyl N-(benzyloxy)carbamate (IX) by means of sodium ethoxide in ethanol yields diethyl 3-(N-benzyloxy-N-methoxycarbonylamino)propylphosphonate (X), which is hydrolyzed with HCl in acetic acid to obtain compound (I). 4) The condensation of (IV) with hydroxylamine by means of NaOH in MeOH-H2O gives diethyl 3-(N-hydroxylamino)propylphosphonate (XI), which is hydrolyzed with HCl in acetic acid to obtain compound (I).

1 Kuroda, Y.; et al.; US 4143135 .
2 Prous, J.R.; Castaner, J.; FR-31564. Drugs Fut 1980, 5, 5, 239.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 39088 3-(hydroxyamino)propylphosphonic acid C3H10NO4P 详情 详情
(II) 12581 1,3-Dibromopropane 109-64-8 C3H6Br2 详情 详情
(III) 12714 diethyl phosphonate; diethyl phosphite 762-04-9 C4H11O3P 详情 详情
(IV) 39080 diethyl 3-bromopropylphosphonate C7H16BrO3P 详情 详情
(V) 39081 butanal oxime 110-69-0 C4H9NO 详情 详情
(VI) 39084 (Z)butylidene[3-(diethoxyphosphoryl)propyl]ammoniumolate C11H24NO4P 详情 详情
(VII) 39083 N-[(4-methoxybenzyl)oxy]-4-methylbenzenesulfonamide C15H17NO4S 详情 详情
(VIII) 39087 diethyl 3-[[(4-methoxybenzyl)oxy][(4-methylphenyl)sulfonyl]amino]propylphosphonate C22H32NO7PS 详情 详情
(IX) 39082 methyl benzyloxycarbamate C9H11NO3 详情 详情
(X) 39086 diethyl 3-[(benzyloxy)(methoxycarbonyl)amino]propylphosphonate C16H26NO6P 详情 详情
(XI) 39085 diethyl 3-(hydroxyamino)propylphosphonate C7H18NO4P 详情 详情

合成路线3

该中间体在本合成路线中的序号:(III)

5) The condensation of 1-chloro-3-bromopropane (XII) with dibutyl phosphonate (XIII) affords dibutyl 3-chloropropylphosphonate (XIV), which by reaction with ethyl N-benzyloxycarbamate (A) is converted into dibutyl 3-(N-benzyloxy-N-ethoxycarbonylamino)propylphosphonate (XV). Finally, this compound is hydrolyzed with HCl in acetic acid to obtain compound (I). 6) The reaction of (XII) with diethyl phosphonate (III) yields diethyl 3-chloropropylphosphonate (XVI), which by condensation with ethyl N-ethoxycarbonyl-oxycarbamate (XVII) is converted into diethyl 3-(N-ethoxycarbonyloxy-N-ethoxycarbonylamino)propylphosphonate (XVIII). Finally, this compound is hydrolyzed with HCl in acetic acid to obtain compound (I).

1 Kuroda, Y.; et al.; US 4143135 .
2 Prous, J.R.; Castaner, J.; FR-31564. Drugs Fut 1980, 5, 5, 239.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(A) 39093 ethyl benzyloxycarbamate C10H13NO3 详情 详情
(I) 39088 3-(hydroxyamino)propylphosphonic acid C3H10NO4P 详情 详情
(III) 12714 diethyl phosphonate; diethyl phosphite 762-04-9 C4H11O3P 详情 详情
(XII) 10358 1-Bromo-3-chloropropane 109-70-6 C3H6BrCl 详情 详情
(XIII) 39089 diethyl 3-chloropropylphosphonate C7H16ClO3P 详情 详情
(XIV) 39091 dibutyl 3-chloropropylphosphonate C11H24ClO3P 详情 详情
(XV) 39095 dibutyl 3-[(benzyloxy)(ethoxycarbonyl)amino]propylphosphonate C21H36NO6P 详情 详情
(XVI) 39090 dibutyl phosphonate 1809-19-4 C8H19O3P 详情 详情
(XVII) 39092 1-[([[(ethoxycarbonyl)amino]oxy]carbonyl)oxy]ethane C6H11NO5 详情 详情
(XVIII) 39094 4-ethoxy-8-(ethoxycarbonyl)-4,10-dioxo-3,9,11-trioxa-8-aza-4lambda(5)-phosphatridecane C13H26NO8P 详情 详情

合成路线4

该中间体在本合成路线中的序号:(III)

10) The condensation of diethyl phosphonate (III) with N-(p-methoxybenzyloxy)-N-(3-chloropropyl)-p-toluenesulfonamide (XXV) by means of NaH in refluxing benzene gives (VIII), which is hydrolyzed with HCl in acetic acid to obtain compound (I). 11) The condensation of (III) with N-(3-chloropropyl)-N-(benzyloxy)-p-toluenesulfonamide (XXVI) by means of NaH in refluxing benzene gives diethyl 3-(N-benzyloxy-N-tosylamino)propylphosphonate (XXVII), which is hydrolyzed with HCl in acetic acid to obtain compound (I). 12) By reaction of 3-bromopropylphosphonic acid (XXVIII) with hydroxylamine by means of sodium methoxide in MeOH to obtain compound (I).

1 Kuroda, Y.; et al.; US 4143135 .
2 Prous, J.R.; Castaner, J.; FR-31564. Drugs Fut 1980, 5, 5, 239.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 39088 3-(hydroxyamino)propylphosphonic acid C3H10NO4P 详情 详情
(III) 12714 diethyl phosphonate; diethyl phosphite 762-04-9 C4H11O3P 详情 详情
(VIII) 39087 diethyl 3-[[(4-methoxybenzyl)oxy][(4-methylphenyl)sulfonyl]amino]propylphosphonate C22H32NO7PS 详情 详情
(XXV) 39102 N-(3-chloropropyl)-N-[(4-methoxybenzyl)oxy]-4-methylbenzenesulfonamide C18H22ClNO4S 详情 详情
(XXVI) 39103 N-(benzyloxy)-N-(3-chloropropyl)-4-methylbenzenesulfonamide C17H20ClNO3S 详情 详情
(XXVII) 39104 diethyl 3-[(benzyloxy)[(4-methylphenyl)sulfonyl]amino]propylphosphonate C21H30NO6PS 详情 详情
(XXVIII) 39105 3-bromopropylphosphonic acid 1190-09-6 C3H8BrO3P 详情 详情

合成路线5

该中间体在本合成路线中的序号:(XX)

3) The reaction of 2(S),3-O-isopropylideneglycerol (XV) with methanesulfonyl chloride and triethylamine in dichloromethane gives the corresponding mesylate (XVI), which is condensed with cytosine (XII) by means of cesium carbonate as before yielding 1-[2(S),3-(isopropylidenedioxy)propyl]cytosine (XVII). The deprotection of (XVII) with aqueous acetic acid at 100 C affords the corresponding diol (XVIII), which is treated with trityl chloride, DMAP and triethylamine in DMF to give the monotrityl compound (XIX). The condensation of (XIX) with diethyl tosyloxymethylphosphonate (VIII) [obtained by reaction of diethylphosphite (XX) with paraformaldehyde, followed by tosylation with tosyl chloride] by a previous treatment of (XX) with DMF dimethylacetal, then condensation by means of NaH in DMF, and a final hydrolysis with hot aqueous acetic acid yields the 1-[2(S)-(diethoxyphosphorylmethoxy)-3-hydroxypropyl]cytosine (XIV) (already obtained), which is finally treated with bromotrimethylsilane as before. 4) The reaction of the acetonide (XVI) with N4-benzoylcytosine (XXI) by means of potassium tert-butoxide or cesium carbonate gives the condensation product (XXII), which is deprotected with HCl in acetic acid yielding the diol (XXIII). The reaction of (XXIII) with trityl chloride and DMAP in refluxing pyridine affords the monotritylated compound (XXIV), which is condensed with the phosphonate (VIII) by means of NaH in DMF to give the fully protected HPMPC compound (XXV). The successive deprotections of (XXV), first with HCl in dichloromethane to eliminate the trityl group yielding (XXVI), then with bromotrimethylsilane to obtain the free phosphono group giving (XXVII), and finally with concentrated aqueous NH4OH to eliminate the benzoyl group affords cidofovir. 5) The benzoylation of acetonide derivative (XVII) with benzoyl anhydride in refluxing pyridine gives the benzoyl citosine derivative (XXII) already obtained.

1 Fromtling, R.A.; Castaner, J.; Cidofovir. Drugs Fut 1996, 21, 10, 1003.
2 Bronson, J.J.; Ferrara, L.M.; Howell, H.G.; Brodfuehrer, P.R.; Martin, J.C.; A new synthesis of the potent and selective anti-herpesvirus agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine. Nucleosides Nucleotides 1990, 9, 6, 745-69.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VIII) 12702 (diethoxyphosphoryl)methyl 4-methylbenzenesulfonate 31618-90-3 C12H19O6PS 详情 详情
(XII) 12706 Cytosine; 4-Amino-2(1H)-pyrimidinone 71-30-7 C4H5N3O 详情 详情
(XIV) 12708 diethyl [[(1S)-2-[4-amino-2-oxo-1(2H)-pyrimidinyl]-1-(hydroxymethyl)ethyl]oxy]methylphosphonate C12H22N3O6P 详情 详情
(XV) 12709 [(4S)-2,2-Dimethyl-1,3-dioxolan-4-yl]methanol 22323-82-6 C6H12O3 详情 详情
(XVI) 12710 [(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl methanesulfonate C7H14O5S 详情 详情
(XVII) 12711 4-Amino-1-[[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl]-2(1H)-pyrimidinone C10H15N3O3 详情 详情
(XVIII) 12695 4-Amino-1-[(2S)-2,3-dihydroxypropyl]-2(1H)-pyrimidinone C7H11N3O3 详情 详情
(XIX) 12713 4-Amino-1-[(2S)-2-hydroxy-3-(trityloxy)propyl]-2(1H)-pyrimidinone C26H25N3O3 详情 详情
(XX) 12714 diethyl phosphonate; diethyl phosphite 762-04-9 C4H11O3P 详情 详情
(XXI) 12715 N-(2-Oxo-1,2-dihydro-4-pyrimidinyl)benzamide; N-Benzoylcytosine 26661-13-2 C11H9N3O2 详情 详情
(XXII) 12716 N-(1-[[(4S)-2,2-Dimethyl-1,3-dioxolan-4-yl]methyl]-2-oxo-1,2-dihydro-4-pyrimidinyl)benzamide C17H19N3O4 详情 详情
(XXIII) 12717 N-[1-[(2S)-2,3-Dihydroxypropyl]-2-oxo-1,2-dihydro-4-pyrimidinyl]benzamide C14H15N3O4 详情 详情
(XXIV) 12718 N-[1-[(2S)-2-Hydroxy-3-(trityloxy)propyl]-2-oxo-1,2-dihydro-4-pyrimidinyl]benzamide C33H29N3O4 详情 详情
(XXV) 12719 diethyl ([(1S)-2-[4-(benzoylamino)-2-oxo-1(2H)-pyrimidinyl]-1-[(trityloxy)methyl]ethyl]oxy)methylphosphonate C38H40N3O7P 详情 详情
(XXVI) 12720 diethyl [[(1S)-2-[4-(benzoylamino)-2-oxo-1(2H)-pyrimidinyl]-1-(hydroxymethyl)ethyl]oxy]methylphosphonate C19H26N3O7P 详情 详情
(XXVII) 12721 [[(1S)-2-[4-(Benzoylamino)-2-oxo-1(2H)-pyrimidinyl]-1-(hydroxymethyl)ethyl]oxy]methylphosphonic acid C15H18N3O7P 详情 详情

合成路线6

该中间体在本合成路线中的序号:(III)

The reaction of cycloheptylamine (I) with triethyl orthoformate (II) and diethyl phosphite (III) at 150 gives cycloheptylaminomethylenediphosphonic acid tetraethyl ester (IV), which is then hydrolyzed with refluxing concentrated hydrochloric acid.

1 Isomura, Y.; Takeuchi, M.; Sakamoto, S.; Abe, T. (Yamanouchi Pharmaceutical Co., Ltd.); (Cycloalkylamino)methylenebisphosphonic acids and medicines containing them. AU 8928670; EP 0325482; JP 1989308290; US 5041428 .
2 Takeuchi, M.; Sakamoto, S.; Kawamuki, K.; Kudo, M.; Murase, K.; Kawashima, H.; Isomura, Y.; Synthesis and structure-activity relationships of a novel anti-resorptive agent YM175, and the related derivatives. Symp Med Chem 1990, P-12.
3 Prous, J.; Castaner, J.; YM-175. Drugs Fut 1992, 17, 4, 293.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 22234 cycloheptanamine; cycloheptylamine 5452-35-7 C7H15N 详情 详情
(II) 21304 Triethyl orthoformate; 1-(Diethoxymethoxy)ethane; Diethoxymethyl ethyl ether 122-51-0 C7H16O3 详情 详情
(III) 12714 diethyl phosphonate; diethyl phosphite 762-04-9 C4H11O3P 详情 详情
(IV) 31262 diethyl [bis(2-hydroxyethyl)phosphoryl](cycloheptylamino)methylphosphonate C16H35NO6P2 详情 详情

合成路线7

该中间体在本合成路线中的序号:(XXII)

3) The catalytic hydrogenation of (S)-glycidol (XVI) over Pd/C gives the (R)-1,2-propanediol (XVII), which is esterified with diethyl carbonate (XVIII)/NaOEt, yielding the cyclic carbonate (XIX). The reaction of (XIX) with adenine (V) by means of NaOH in DMF affords 9-[2(R)-hydroxypropyl]adenine (VII), which is condensed with tosyloxymethylphosphonic acid diethyl ester (XX) by means of lithium tert-butoxide in THF, giving 9-[2(R)-(diethoxyphosphorylmethoxy)propyl]adenine (XXI). Finally, this compound is hydrolyzed with bromotrimethylsilane as before. Compound (XX) is obtained by reaction of diethyl phosphite (XXII) with paraformaldehyde, yielding hydroxy- methylphosphonic acid diethyl ester (XXIII), which is finally tosylated as usual.

1 Leone-Bay, A.; et al.; 4-(4-Salicyloylaminophenyl)butyric acid as a novel oral delivery agent for recombinant human growth hormone. 211th ACS Natl Meet (March 24-28, New Orleans) 1996, Abst MEDI 006.
2 Schultze, L.M.; Chapman, H.H.; Dubree, N.J.P.; et al.; Practical synthesis of the anti-HIV drug, PMPA. Tetrahedron Lett 1998, 39, 14, 1853.
3 Sorbera, L.A.; Castañer, J.; (R)-PMPA and Bis(POC)PMPA. Drugs Fut 1998, 23, 12, 1279.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(V) 10343 9H-Purin-6-amine; 9H-Purin-6-ylamine; Adenine 73-24-5 C5H5N5 详情 详情
(VII) 19232 (2S)-1-(6-amino-9H-purin-9-yl)-2-propanol C8H11N5O 详情 详情
(XVI) 19241 (2S)oxiranylmethanol 60456-23-7 C3H6O2 详情 详情
(XVII) 19242 (2S)-1,2-propanediol 4254-15-3 C3H8O2 详情 详情
(XVIII) 17470 diethyl carbonate; diethylcarbonate 105-58-8 C5H10O3 详情 详情
(XIX) 19244 (4S)-4-methyl-1,3-dioxolan-2-one C4H6O3 详情 详情
(XX) 12702 (diethoxyphosphoryl)methyl 4-methylbenzenesulfonate 31618-90-3 C12H19O6PS 详情 详情
(XXI) 19246 diethyl [[(1S)-2-(6-amino-9H-purin-9-yl)-1-methylethyl]oxy]methylphosphonate C13H22N5O4P 详情 详情
(XXII) 12714 diethyl phosphonate; diethyl phosphite 762-04-9 C4H11O3P 详情 详情
(XXIII) 19248 diethyl hydroxymethylphosphonate 3084-40-0 C5H13O4P 详情 详情

合成路线8

该中间体在本合成路线中的序号:(III)

The title compound was originally isolated from the fermentation broths of Streptomyces rubellomurinus. The chemical synthesis of this compound was further described. Treatment of O-benzyl hydroxylamine (I) with TsCl in pyridine afforded N-(benzyloxy)-p-toluenesulfonamide (II). A closely related procedure used O-(p-methoxy-benzyl)hydroxylamine. Diethyl (3-bromopropyl)phosphonate (V) was obtained by alkylation of the sodium salt of diethyl phosphonate (III) with 1,3-dibromopropane (IV). Related procedures used dibutyl phosphonate or 1-bromo-3-chloropropane instead of (III) or (IV). The condensation of protected hydroxylamine (II) with bromide (V) in the presence of NaH furnished adduct (VI). Alternatively, intermediate (VI) was prepared by first alkylation of N-(benzyloxy)-p-toluenesulfonamide (II) with 1,3-dibromopropane (IV) to give (VII), and then condensation of bromide (VII) with the sodium salt of diethyl phosphonate (III). Hydrolysis of (VI) with HCl in HOAc gave rise to 3-(N-hydroxyamino)propylphosphonic acid (VIII). This was finally acetylated with Ac2O in NaOH.

1 Takashi, K.; et al.; Studies on phosphonic acid antibiotics. I. Structure and synthesis 3-(N-acetyl-N-hydroxyamino) propylphosphonic acid (FR-900098) and its N-formyl analog (FR-31564). Tetrahedron Lett 1980, 21, 1, 95.
2 Iguchi, E.; et al.; Studies on new phosphonic acid antibiotics II. Taxonomic studies on producing organisms of the phosphonic acid and related compounds. J Antibiot 1980, 33, 1, 18.
3 Takeno, H.; Hemmi, K.; Hashimoto, M.; Kamiya, T. (Fujisawa Pharmaceutical Co., Ltd.); Hydroxyaminohydrocarbonphosphonic acids. DE 2733658; US 4182758; US 4206156 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 14640 O-benzylhydroxylamine; 1-[(aminooxy)methyl]benzene 622-33-3 C7H9NO 详情 详情
(II) 39517 N-(benzyloxy)-4-methylbenzenesulfonamide C14H15NO3S 详情 详情
(III) 12714 diethyl phosphonate; diethyl phosphite 762-04-9 C4H11O3P 详情 详情
(IV) 12581 1,3-Dibromopropane 109-64-8 C3H6Br2 详情 详情
(V) 39080 diethyl 3-bromopropylphosphonate C7H16BrO3P 详情 详情
(VI) 39104 diethyl 3-[(benzyloxy)[(4-methylphenyl)sulfonyl]amino]propylphosphonate C21H30NO6PS 详情 详情
(VII) 39517 N-(benzyloxy)-4-methylbenzenesulfonamide C14H15NO3S 详情 详情
(VIII) 39088 3-(hydroxyamino)propylphosphonic acid C3H10NO4P 详情 详情

合成路线9

该中间体在本合成路线中的序号:(IV)

Treatment of adenosine (I) with ethylene carbonate (II) in the presence of NaOH in refluxing DMF gives 9-(2-hydroxyethyl)adenosine (III). Diethyl phosphite (IV) is then condensed with formaldehyde, followed by reaction with p-toluenesulfonyl chloride and Et3N to afford diethyl (tosyloxymethyl)phosphonate (V). Subsequent condensation of tosylate (V) with (III) in the presence of t-BuONa gives the phosphonyloxymethoxyethyl adenosine (PMEA) diethyl ester (VI), which is hydrolyzed to the corresponding phosphonic acid adefovir (VII) by means of in situ-generated iodotrimethylsilane. The condensation of phosphonic acid (VII) with 1(S)-(3-chlorophenyl)-1,3-propanediol (VIII) utilizing DCC/pyridine leads to the cyclic phosphonate (IX) as a roughly equimolecular mixture of diastereoisomers, which can be chromatographically separated to furnish the title cis-isomer pradefovir. In an improved procedure, activation of adefovir (VII) with oxalyl chloride and N,N-diethylformamide generates the formamidine-protected phosphonyl dichloridate (X), which upon condensation with diol (VIII) at low temperature gives the cyclic phosphonate (XI) as a mixture in which the desired cis-diastereoisomer predominates. After hydrolysis of the formamidine (XI) with ethanolic AcOH, recrystallization as the corresponding mesylate salt provides the title adefovir prodrug in high diastereomeric excess (1-5). Scheme 1.

1 Kopcho, J.J., Matelich, M.C., Reddy, K.R., Ugarkar, B.G. (Metabasis Therapeutics, Inc.). Process for preparation of cyclic prodrugs of PMEA and PMPA. JP 2005525422, US 2003225277, WO 2003095665.
2 Erion, M.D., Kopcho, J.J., Matelich, M.C., Reddy, K.R. (Metabasis Therapeutics, Inc.). Novel phosphonic acid based prodrugs of PMEA and its analogues. EP 1532157, US 2003229225, WO 2004037161.
3 Reddy, K.R., Matelich, M.C., Ugarkar, B.G. et al. HepDirect prodrugs of adefovir: Design, synthesis and optimization. 227th ACS Natl Meet (March 28-April 1, Anaheim) 2004, Abst MEDI- 27.
4 Martin, K. (Metabasis Therapeutics, Inc.). Lewis acid mediated synthesis of cyclic esters. CA 2565966, EP 1753762, US 2005282782, WO 2005123729.
5 Erion, M.D., Reddy, K.R., Boyer, S.H. et al. Design, synthesis, and characterization of a series of cytochrome P450 3A-activated prodrugs (HepDirect prodrugs) useful for targeting phospho(on)ate-based drugs to the liver. J Am Chem Soc 2004, 126(16): 5154-63.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 10343 9H-Purin-6-amine; 9H-Purin-6-ylamine; Adenine 73-24-5 C5H5N5 详情 详情
(II) 32802 1,3-dioxolan-2-one 96-49-1 C3H4O3 详情 详情
(III) 39672 2-(6-amino-9H-purin-9-yl)-1-ethanol C7H9N5O 详情 详情
(IV) 12714 diethyl phosphonate; diethyl phosphite 762-04-9 C4H11O3P 详情 详情
(V) 12702 (diethoxyphosphoryl)methyl 4-methylbenzenesulfonate 31618-90-3 C12H19O6PS 详情 详情
(VI) 39673 diethyl [2-(6-amino-9H-purin-9-yl)ethoxy]methylphosphonate C12H20N5O4P 详情 详情
(VII) 16165 [2-(6-amino-9H-purin-9-yl)ethoxy]methylphosphonic acid C8H12N5O4P 详情 详情
(VIII) 65232 1(S)-(3-chlorophenyl)-1,3-propanediol   C9H11ClO2 详情 详情
(IX) 65233     C17H19ClN5O4P 详情 详情
(X) 65234     C13H19Cl2N6O2P 详情 详情
(XI) 65235     C22H28ClN6O4P 详情 详情
Extended Information